Meet Dr. Bruce Sahba, MD
A career dedicated to advancing gastroenterology and patient-centered care.
For over five and a half decades, Dr. Bruce Sahba, MD has been a cornerstone of the medical community, blending extensive clinical practice with groundbreaking research in gastroenterology.
His foundational medical education was completed at the prestigious School of Medicine Tehran, where he cultivated the expertise and dedication that would define his career.
With 55+ years of experience, Dr. Sahba possesses a profound understanding of complex gastrointestinal conditions, offering patients in Fresno and beyond not just treatment, but a partnership in health.
His passion extends beyond the consultation room into vital GI safety and tolerability research, including significant clinical studies in San Diego, ensuring his practice is informed by the very latest medical advancements.
Dr. Sahba’s philosophy is simple: every patient deserves compassionate, expert care tailored to their unique needs. His dual commitment to hands-on patient care and contributing to the future of gastroenterology makes him a trusted authority for both individuals seeking relief and institutions seeking collaborative expertise.
Bridging Clinical Practice & Medical Research
Dr. Sahba's work extends beyond the exam room into the research laboratory, where he contributes to advancing gastroenterological science and improving patient outcomes on a broader scale.
San Diego Clinical Studies
Actively involved in San Diego-based clinical studies focused on gastrointestinal safety and medication tolerability, ensuring treatments are both effective and safe for patients.
Key Research Contributions
- Alendronate safety profiles in GI systems
- Lansoprazole superiority studies for acid control
- H. pylori eradication protocols and resistance
Collaborative Expertise
This dual role as clinician and researcher allows Dr. Sahba to bring the latest evidence-based practices directly to his patients in Fresno while contributing valuable data to the medical community.
Medical institutions and research partners are invited to call to discuss collaboration opportunities in GI safety studies.